I’m back from IDWeek 2017 in San Diego — always good to reconnect with old friends, meet new colleagues, and hear the latest in infection prevention and antibiotic stewardship science and practice. This year I noted an increase in pro-con and clinical controversies sessions, which I think are so valuable for those of us struggling day-to-day with issues where the evidence base is absent or opinion is conflicting. If you didn’t get a chance to attend, fear not, as I am sure there will be more conference-related news emerging over the coming weeks (all 6 of your favorite bloggers made an appearance).
Of course, it’s never too early to think about next year — IDWeek 2018 heads back to the left coast, this time it’s San Francisco, October 3-7, 2018 (mark your calendars!). I’m among the SHEA contingent for the planning committee (along with Hilary), and we’re very interested in program suggestions — please send them our way.
I’ll leave you with one meeting tidbit — Shelley Magill presented the results from the CDC’s 2015 HAI Prevalence study, a follow up to their 2011 survey that was published in the NEJM. In the 4 years since the first survey (using the same hospitals included previously):
- The HAI prevalence rate among hospitalized acute care patients fell from 4.1% to 3.2% (a 22% decrease)
- Central line and urinary catheter use were both significantly lower
- Healthcare-associated UTIs and SSIs significantly decreased